Pharmacologic Targeting of ZNF281 Suppresses Metastatic Prostate Cancer Beyond Androgen Receptor Dependence
This study reveals the previously uncharacterized of ZNF281 in promoting androgen receptor–dependent transcription and androgen receptor-independent proliferative and metastatic programs in prostate cancer, advances understanding of disease progression across different androgen receptor expression statuses, and establi...